Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial

BACKGROUND/AIM: To evaluate efficacy and safety of bimatoprost 0.03% preservative-free (PF) ophthalmic solution versus bimatoprost 0.03% (Lumigan) ophthalmic solution for glaucoma or ocular hypertension. METHODS: In this double-masked, parallel-group study, patients were randomised to bimatoprost PF...

Descripción completa

Detalles Bibliográficos
Autores principales: Day, Douglas G, Walters, Thomas R, Schwartz, Gail F, Mundorf, Thomas K, Liu, Charlie, Schiffman, Rhett M, Bejanian, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717762/
https://www.ncbi.nlm.nih.gov/pubmed/23743437
http://dx.doi.org/10.1136/bjophthalmol-2012-303040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717762/
https://www.ncbi.nlm.nih.gov/pubmed/23743437
http://dx.doi.org/10.1136/bjophthalmol-2012-303040

Ejemplares similares